GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity (Q48819023)

From Wikidata
Jump to navigation Jump to search
scientific article published in July 2001
edit
Language Label Description Also known as
English
GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity
scientific article published in July 2001

    Statements

    GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit